Blood Pressure Control During Exercise in Heart Failure

心力衰竭运动期间的血压控制

基本信息

  • 批准号:
    7915291
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-07-08 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

Over 5 million Americans suffer from heart failure with over a half a million newly diagnosed cases each year. The annual cost of treatment is approaching 40 billion dollars with over 20 billion dollars in hospital expenses alone. The incidence of heart failure increases with age and is markedly higher amongst minority populations. Therefore, heart failure presents a major health problem in the United States as well as worldwide. Exercise intolerance is a classic symptom of heart failure. Even moderate exercise may leave the patient exhausted and out of breath. In this setting often extreme activation of the sympathetic nervous system occurs causing profound peripheral vasoconstriction. Even the coronary vasculature may be vasoconstricted causing local ischemia and increased incidence of ventricular arrhythmias and sudden cardiac death. The mechanisms mediating this exaggerated activation of the sympathetic nervous system during exercise in subjects with heart failure are poorly understood. Previous studies have implicated abnormal activation of the muscle metaboreflex in mediating these responses. This competing renewal proposal is focused on expanding our investigations of altered neural control of cardiovascular function during exercise in heart failure. We will utilize our innovative and highly complex conscious, chronically instrumented canine model. Our long term goal is to further elucidate the mechanisms responsible for the heightened activation of the sympathetic nervous system during exercise in heart failure and the functional consequences of these responses in the integrative control of cardiovascular function. This proposal is focused on the altered neuronal control of coronary blood flow and the impact on ventricular function during exercise in heart failure. A major strength of the proposal is our unique capability of simultaneous measurement of a number of critical central and peripheral hemodynamic parameters in real time at rest and during exercise in the same animals before and after induction of heart failure. These longitudinally designed experiments we feel will provide compelling new information on the altered mechanisms of cardiovascular control during exercise in heart failure.
超过500万美国人患有心力衰竭,每年有超过50万新诊断病例。每年的治疗费用接近400亿美元,仅医院费用就超过200亿美元。心力衰竭的发病率随着年龄的增长而增加,在少数民族人群中明显更高。因此,心力衰竭在美国乃至全世界都是一个主要的健康问题。运动不耐受是心力衰竭的典型症状。即使是适度的运动也可能使病人精疲力竭,上气不接下气。在这种情况下,交感神经系统的极端激活经常发生,引起严重的周围血管收缩。甚至冠状动脉血管也可能收缩,引起局部缺血,增加室性心律失常和心源性猝死的发生率。在心力衰竭患者运动过程中,交感神经系统过度激活的机制尚不清楚。先前的研究表明,肌肉代谢反射的异常激活介导了这些反应。这一竞争性更新建议的重点是扩大我们对心力衰竭患者运动期间心血管功能神经控制改变的研究。我们将利用我们的创新和高度复杂的意识,长期仪器犬模型。我们的长期目标是进一步阐明在心力衰竭运动中交感神经系统激活增强的机制,以及这些反应在心血管功能综合控制中的功能后果。这一建议的重点是改变神经元控制冠状动脉血流和心室功能在心力衰竭运动期间的影响。该建议的一个主要优势是我们在诱导心力衰竭之前和之后的同一动物中,在休息和运动期间实时测量一些关键的中央和外周血液动力学参数的独特能力。我们认为这些纵向设计的实验将为心力衰竭患者在运动过程中心血管控制的改变机制提供令人信服的新信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donal S O'Leary其他文献

Donal S O'Leary的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donal S O'Leary', 18)}}的其他基金

Mechanisms Mediating Enhanced Sympatho-Activation During Exercise in Hypertension
高血压运动期间交感神经激活增强的介导机制
  • 批准号:
    9034873
  • 财政年份:
    2016
  • 资助金额:
    $ 38万
  • 项目类别:
Blood Pressure Control During Exercise in Heart Failure
心力衰竭运动期间的血压控制
  • 批准号:
    7822187
  • 财政年份:
    2009
  • 资助金额:
    $ 38万
  • 项目类别:
Integrative Cardiovascular Control During Exercise in Hypertension
高血压运动期间的综合心血管控制
  • 批准号:
    7635500
  • 财政年份:
    2009
  • 资助金额:
    $ 38万
  • 项目类别:
Integrative Cardiovascular Control During Exercise in Hypertension
高血压运动期间的综合心血管控制
  • 批准号:
    7860572
  • 财政年份:
    2009
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Adenosine Receptors in Cardiovascular Control
NTS 腺苷受体在心血管控制中的作用
  • 批准号:
    7822257
  • 财政年份:
    2009
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Adenosine Receptors in Cardiovascular Control
NTS 腺苷受体在心血管控制中的作用
  • 批准号:
    7259181
  • 财政年份:
    2007
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Adenosine Receptors in Cardiovascular Control
NTS 腺苷受体在心血管控制中的作用
  • 批准号:
    7800969
  • 财政年份:
    2007
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Adenosine Receptors in Cardiovascular Control
NTS 腺苷受体在心血管控制中的作用
  • 批准号:
    7391831
  • 财政年份:
    2007
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Adenosine Receptors in Cardiovascular Control
NTS 腺苷受体在心血管控制中的作用
  • 批准号:
    7591033
  • 财政年份:
    2007
  • 资助金额:
    $ 38万
  • 项目类别:
NTS Purinoreceptor in Integrative Cardiovascular Control
NTS 嘌呤受体在心血管综合控制中的应用
  • 批准号:
    6579955
  • 财政年份:
    2002
  • 资助金额:
    $ 38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了